Clinical application of NGAL/MAU

NGAL/MAU combo test is of great importance for signs of changes in the entire vascular system, early indications of changes in the renal and cardiovascular systems, and renal function tests after transplantation.

Specific clinical applications of NGAL/MAU combo test are shown below:

① NGAL/MAU combo test is useful for early detection of renal injury and has clinical value in the development and progression of diabetic kidney disease, as well as in treatment outcomes.

② NGAL/MAU combo test provides an important indicator for early AKI or acute renal failure (ARF) complicated by various types of surgery.

③ NGAL/MAU combo test is closely related to the degree of renal damage in patients with hypertension, and its combo test can increase the detection rate of early diagnosis in patients with hypertensive nephropathy, which has an important clinical value for early intervention and early treatment.

The ReLIA NGAL/MAU(2 in 1) Immunoassay is CE-marked cleared. For more details on ReLIA NGAL/MAU(2 in 1) Immunoassay products and prices please contact us at  marketing@ReLIAchina.com